Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Short term Debt (2019 - 2020)

aTYR PHARMA's Short term Debt history spans 2 years, with the latest figure at $3.1 million for Q3 2020.

  • For Q3 2020, Short term Debt fell 60.98% year-over-year to $3.1 million; the TTM value through Sep 2020 reached $3.1 million, down 60.98%, while the annual FY2019 figure was $8.7 million, N/A changed from the prior year.
  • Short term Debt reached $3.1 million in Q3 2020 per ATYR's latest filing, down from $5.0 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $8.7 million in Q4 2019 to a low of $3.1 million in Q3 2020.